CARDIOMYO, the European consortium project led by ZeClinics and its partners Taros Chemicals and Amsterdam University Medical Centers, has been awarded with a budget of 2,4 million euros from the prestigious EUREKA- EUROSTARS innovation program.
Read more
EFMC-ISMC 2021 will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, diseases of the brain, heart, and respiratory system, fibrotic diseases and cancer. EFMC-ISMC 2021 will also feature most recent advances in new technologies such as…
The French Medicinal Chemistry Society is pleased to invite to the 56th edition of the International Conference on Medicinal Chemistry.
At BIO Digital more than 5,000 participants from 55 countries come together for a One-on-One Partnering, education and networking with professionals from life science and pharmaceutical industry…
The Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates…
LOPEC is the leading trade fair and the most important conference for the printed electronics industry. It is the leading global platform for the industry and provides guidance in every aspect of the industry, from application to research…
The BIO-Europe® Spring takes place annually in changing cities and is an international forum for promoting business development between pharmaceutical, financial and biotechnology companies…
The 34th electronic displays Conference (edC) will act again as a major forum for the presentation of innovative ideas, approaches, developments and research projects in the area of today’s and future display business. From 26 to 27 February 2020, developers, scientists and users of electronic displays will…
A consortium comprising Grünenthal, Taros Chemicals and three research groups from the Institute for Neurosciences and Medicine (INM) of the Research Centre Jülich employed positron emission tomography (PET) as imaging method to investigate the interaction of a single drug with two specific targets…
Cardiovascular diseases are still one of the most frequent causes of death. Since the heart muscle cannot regenerate itself, the tissue is usually remodeled leading to impaired heart function in the long term. Many patients who have survived a heart attack suffer from cardiac insufficiency years later…
